Dydrogesterone as an Option in the Medical Treatment of Endometriosis: A Brief Comment

article OA: diamond CC0
AI-generated summary by claude@2026-06, 2026-06-08

This comment discusses dydrogesterone as a cost-effective, accessible, and acceptable long-term medical management option for endometriosis-related pain and morbidity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis-related pain and morbidity are assumed to cause substantial impact on quality of life. Due to its chronicity, the disease is expected to be clinically managed in a long-term individualized plan, considering easy access, cost-effectiveness, acceptance, and adherence, regardless of surgical interventions, when (and if) they are necessary.

My notes (saved in your browser only)

Condition tags

mesh:D004715endometriosis

MeSH descriptors

Dydrogesterone Dydrogesterone Dydrogesterone Dydrogesterone Dydrogesterone Dydrogesterone Dydrogesterone Dydrogesterone Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Female Female Female Female

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (14)

Source provenance

europepmc
last seen: 2026-06-04T01:30:01.192114+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-22T00:34:53.982986+00:00
License: CC0 · commercial use OK